Observational studyFrontiers in immunology2021

Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study.

Javier Riancho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.